Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine vs Midazolam for Difficult-to-treat Depression
NCT05026203Phase 4Completed
- Sponsor
- Mahidol University
- Start
- Sep 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in major depressive disorder (MDD), sponsored by Mahidol University. Started Sep 2021; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05026203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05026203.